A drug-eluting stent explained simply: it is a coronary stent that combines a metal mesh scaffold with a coating that gradually releases medication into the artery wall after placement. This dual-function design, mechanical support plus localized drug delivery, has become a widely used approach in modern interventional cardiology for treating coronary artery disease. This article walks through how drug-eluting stents work and what patients commonly want to understand before a procedure.
What Makes a Stent "Drug-Eluting"?
The term "drug-eluting" refers to the medicated coating applied to the stent's metal surface. After the stent is expanded inside the artery, this coating releases its medication gradually over a period of weeks, delivering the drug directly to the surrounding vessel tissue rather than through the bloodstream generally.
- The metal scaffold (often cobalt-chromium) provides the mechanical structure that holds the artery open.
- The coating contains an anti-proliferative medication, such as sirolimus, embedded in a polymer or delivery matrix.
- Drug release is designed to occur gradually as the polymer breaks down or elutes over time.
- The intent is to influence the local healing response at the treatment site, rather than to treat the disease itself.
INVAMED's ATLAS drug-eluting stent, for example, uses a sirolimus coating at 1 µg/mm² on a laser-cut cobalt-chromium L605 frame.
Why Is the Drug Coating Used?
After any stent is placed, the artery undergoes a natural healing response as tissue grows to incorporate the device. In some patients, this healing process becomes excessive, leading to a buildup of scar-like tissue that can renarrow the artery, a process known as in-stent restenosis.
The medication in a drug-eluting stent's coating is designed to help moderate this excessive tissue growth at the local level. This localized approach is intended to reduce the likelihood of significant restenosis compared to a bare-metal stent, though it does not eliminate the possibility entirely, and individual outcomes vary.
What Should Patients Understand About Follow-Up Care?
Because the healing process around a drug-eluting stent takes time, physicians commonly prescribe antiplatelet medication for a defined period after the procedure. This medication helps reduce the risk of clot formation on the stent surface while the artery heals and the device becomes incorporated into the vessel wall. Patients should take these medications exactly as prescribed and should never stop or adjust them without speaking directly to their cardiologist first, even if they are feeling well.
Are Drug-Eluting Stents Right for Everyone?
Not every patient or every blockage is suited to a drug-eluting stent. The decision depends on factors such as vessel size, lesion complexity, bleeding risk, and the patient's ability to safely complete the prescribed antiplatelet therapy course. Some patients may be better suited to a bare-metal stent or an entirely different treatment approach. This decision is made individually by the treating cardiologist, and all stenting procedures carry risks that should be discussed directly with the care team.
Frequently Asked Questions
How long does the drug in a drug-eluting stent last?
Drug release typically occurs over a period of weeks following implantation, though the metal scaffold itself remains in place permanently. Specific release timelines vary by device and manufacturer; a cardiologist can provide details relevant to the specific stent used.
Does the drug coating affect the whole body?
Drug-eluting stents are designed to deliver medication locally to the vessel wall at the treatment site rather than achieving significant systemic drug levels, which is intended to minimize broader body-wide drug exposure compared to oral medications.
Is a drug-eluting stent more expensive than a bare-metal stent?
Cost considerations vary by healthcare system, country, and insurance or reimbursement structure, and INVAMED does not provide pricing information through this educational content. Patients should discuss cost-related questions with their care team, hospital, or insurance provider.
Related INVAMED Resources
- ATLAS Drug Eluting Coronary Stent System Cobalt Chromium
- Bare-Metal vs Drug-Eluting Stents: Key Differences
- In-Stent Restenosis Explained: Causes and Management
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.